KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Account Payables: 2015-2025

Historic Change in Account Payables for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to -$10.7 million.

  • Medpace Holdings' Change in Account Payables fell 1761.98% to -$10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 228.67%. This contributed to the annual value of -$3.0 million for FY2024, which is 382.11% down from last year.
  • Latest data reveals that Medpace Holdings reported Change in Account Payables of -$10.7 million as of Q3 2025, which was down 924.37% from $1.3 million recorded in Q2 2025.
  • Medpace Holdings' 5-year Change in Account Payables high stood at $10.7 million for Q1 2025, and its period low was -$10.7 million during Q3 2025.
  • For the 3-year period, Medpace Holdings' Change in Account Payables averaged around -$56,182, with its median value being $64,000 (2024).
  • In the last 5 years, Medpace Holdings' Change in Account Payables soared by 2,093.31% in 2022 and then plummeted by 1,761.98% in 2025.
  • Quarterly analysis of 5 years shows Medpace Holdings' Change in Account Payables stood at -$284,000 in 2021, then soared by 2,093.31% to $5.7 million in 2022, then slumped by 65.17% to $2.0 million in 2023, then tumbled by 96.75% to $64,000 in 2024, then slumped by 1,761.98% to -$10.7 million in 2025.
  • Its last three reported values are -$10.7 million in Q3 2025, $1.3 million for Q2 2025, and $10.7 million during Q1 2025.